Catalyst Wire Dossier Catalyst Wire Dossier

S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine

S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine, covering 2022-01-11 to 2022-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years Old [Phase 2]

See pricing